Tony Lin-Wei Chen, Anirudh Buddhiraju, Blake M Bacevich, Henry Hojoon Seo, Michelle Riyo Shimizu, Young-Min Kwon
{"title":"Predicting 30-day reoperation following primary total knee arthroplasty: machine learning model outperforms the ACS risk calculator.","authors":"Tony Lin-Wei Chen, Anirudh Buddhiraju, Blake M Bacevich, Henry Hojoon Seo, Michelle Riyo Shimizu, Young-Min Kwon","doi":"10.1007/s11517-024-03258-x","DOIUrl":null,"url":null,"abstract":"<p><p>The ACS risk calculator (ARC) has proven less effective in predicting patient-specific risk of early reoperation after primary total knee arthroplasty (TKA), compromising care quality and cost efficiency. This study compared the performance of a machine learning (ML) model and ARC in predicting 30-day reoperation after primary TKA using a national-scale dataset. Data of 366,151 TKAs were acquired from the ACS-NSQIP database. A random forest model was derived using ARC build-in parameters from the training dataset via techniques of hyperparameter optimization and cross-validation. The predictive performance of random forest and ARC was evaluated by metrics of discrimination, calibration, and clinical utility using the testing dataset. The ML model demonstrated good discrimination and calibration (AUC: 0.72, slope: 1.18, intercept: - 0.14, Brier score: 0.012), outperforming ARC in all metrics (AUC: 0.51, slope: - 0.01, intercept: 0.01, Brier score: 0.135) including clinical utility measured by decision curve analyses. Age (> 67 years) and BMI (> 34 kg/m<sup>2</sup>) were the important predictors of reoperation. This study suggests the superiority of ML models in identifying individualized 30-day reoperation risk following TKA. ML models may be an adjunct prediction tool in enhancing patient-specific risk stratification and postoperative care management.</p>","PeriodicalId":49840,"journal":{"name":"Medical & Biological Engineering & Computing","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical & Biological Engineering & Computing","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s11517-024-03258-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS","Score":null,"Total":0}
引用次数: 0
Abstract
The ACS risk calculator (ARC) has proven less effective in predicting patient-specific risk of early reoperation after primary total knee arthroplasty (TKA), compromising care quality and cost efficiency. This study compared the performance of a machine learning (ML) model and ARC in predicting 30-day reoperation after primary TKA using a national-scale dataset. Data of 366,151 TKAs were acquired from the ACS-NSQIP database. A random forest model was derived using ARC build-in parameters from the training dataset via techniques of hyperparameter optimization and cross-validation. The predictive performance of random forest and ARC was evaluated by metrics of discrimination, calibration, and clinical utility using the testing dataset. The ML model demonstrated good discrimination and calibration (AUC: 0.72, slope: 1.18, intercept: - 0.14, Brier score: 0.012), outperforming ARC in all metrics (AUC: 0.51, slope: - 0.01, intercept: 0.01, Brier score: 0.135) including clinical utility measured by decision curve analyses. Age (> 67 years) and BMI (> 34 kg/m2) were the important predictors of reoperation. This study suggests the superiority of ML models in identifying individualized 30-day reoperation risk following TKA. ML models may be an adjunct prediction tool in enhancing patient-specific risk stratification and postoperative care management.
期刊介绍:
Founded in 1963, Medical & Biological Engineering & Computing (MBEC) continues to serve the biomedical engineering community, covering the entire spectrum of biomedical and clinical engineering. The journal presents exciting and vital experimental and theoretical developments in biomedical science and technology, and reports on advances in computer-based methodologies in these multidisciplinary subjects. The journal also incorporates new and evolving technologies including cellular engineering and molecular imaging.
MBEC publishes original research articles as well as reviews and technical notes. Its Rapid Communications category focuses on material of immediate value to the readership, while the Controversies section provides a forum to exchange views on selected issues, stimulating a vigorous and informed debate in this exciting and high profile field.
MBEC is an official journal of the International Federation of Medical and Biological Engineering (IFMBE).